Product Images Zenchent Fe

This is a list of studies conducted on the risk of breast cancer associated with combined oral contraceptive use. The text provides the name of the studies, their respective dates, and whether they focus on current or ever use of contraceptives. The studies include: NICHO Women's Contraceptive Study in 2002, French E3N cohort Study in 2005, Shanga Women's Health study in 2009, The Nurses' Health Study in 2010, and the Xtord Family Planning Association Study in 2013. The Danish Sex Hormone Register Study of 2017 is also mentioned. The text ends with a table with Effect Estimates (OR/RR).*

This text describes the effectiveness of different methods of birth control in terms of the number of pregnancies per 100 women in one year. It also lists various types of birth control methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days of the monthly cycle, spermicide, and withdrawal. It provides a visual representation of the effectiveness of these methods in preventing pregnancies based on the number of pregnancies that can occur per 100 women in one year.*

Zenchent Fe is a contraceptive pill that helps to prevent pregnancy. Each packet contains 3 dispensers of 28 tablets that must be taken as per the instructions. Each dispenser contains a cycle of 28 tablets which includes 21 yellow tablets that contain 0.4mg of Norethindrone and 35mcg of Ethinyl Estradiol, and 7 natural brown tablets that contain 0.75mg of Ferrous Fumarate. The packet has a lot number and expiration date mentioned on the non-varnish area.*

Zenchent Fe is a chewable tablet that contains a combination of Norethindrone and Ethinyl Estradiol, along with Ferrous Fumarate Tablets. It is designed to be used as an oral contraceptive to prevent unwanted pregnancy. The package contains one blister card with 28 tablets, and it is distributed by Amneal Pharmaceuticals LLC. The product is not intended to protect against HIV or other sexually transmitted diseases. The lot and expiry information are also printed on the package for reference.*

This is a description of a medication package. The package contains tablets that are inactive in the fourth week. The medication package contains Norethindrone Acetate and Ethinyl Estradiol Tablets and Ferrous Fumarate Tablets. The package also includes a monthly self-breast exam guide. The text is clear and readable.*